Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Full NameDr Annette Byrne
Dept of Physiology and Medical Physics
Royal College of Surgeons in Ireland
Webpage:rcsi.ie
Email hidden; Javascript is required.
- cancer/oncology
- Surgery
- Pathology
- Gastroenterology
- Oncology
- Pharmacology
- Physiology
- Vascular Medicine
We are concerned with the pre-clinical development of novel targeted anti-cancer therapeutics and biomarkers with a particular interest in applying a multi-modality molecular imaging approach towards elucidation of drug mechanism of action in vivo. We also have a particular interest in the identification and screening of novel targets in vivo with specific expertise implementing PDX models. In addition we are also involved in the interrogation of new safety and efficacy biomarkers for clinically approved targeted therapies. Technologies include optical, nuclear, CT and MR imaging approaches and the development of imageable disease models. Our group works primarily on colorectal, brain and breast malignancies.
See URLs: www.coloforetell.ie; www.angiopredict.com; www.breastpredict.com
Example Publication:
O'Halloran PJ, Viel T, Murray DW, Wachsmuth L, Schwegmann K, Wagner S, Kopka K, Jarzabek MA, Dicker P, Hermann S, Faber C, Klasen T, Schafers M, O'Brien D, Prehn JH, Jacobs AH, Byrne AT. Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.
Eur J Nucl Med Mol Imaging 2016 Aug;43(9):1673-83.